Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis

• Auteurs principaux: Dun Wang (Auteur), Lingling Ge (Auteur), Zizhen Guo (Auteur), Yuehua Li (Auteur), Beiyao Zhu (Auteur), Wei Wang (Auteur), Chengjiang Wei (Auteur), Qingfeng Li (Auteur), Zhichao Wang (Auteur)
• Format: Livre
• Publié: MDPI AG, 2022-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Trametinib has been used in neurofibromatosis type 1 (NF1) patients, especially those with unresectable nerve tumors, but no systematic review based on the latest studies has been published. We conducted this meta-analysis to evaluate the effectiveness and safety of trametinib in treating NF1-relate...